Association Between CD147 Expression, RAS Mutational Status, and Local Recurrence in Resected Locally Advanced Rectal Cancer

ABSTRACT Aim About 5% to 10% of rectal cancer (RC) patients experience local disease recurrence after chemoradiotherapy (CRT) and surgery. Identifying patients at high risk of local recurrence (LR) could lead to the personalized management of the patients. Multiple clinicopathological parameters are...

Full description

Bibliographic Details

Published in:	Cancer Medicine
Main Authors:	Anaëlle Isnard, Laure‐Amandine Cramier, Rémi Vergara, Mehdi Boubaddi, Donatien Fouche, Benjamin Fernandez, Nathalie Senant, Quentin Denost, Éric Rullier, Pierre Dubus, Sandrine Dabernat, Charles Dupin, Véronique Vendrely, Anne Rullier, Samuel Amintas
Format:	Article
Language:	English
Published:	Wiley 2025-08-01
Subjects:	BRAF CD147 EMMPRIN gender KRAS local recurrence
Online Access:	https://doi.org/10.1002/cam4.71087